Bio
Dr Aaron Tan is currently an Associate Consultant at the National Cancer Centre Singapore (NCCS), having completed his specialty training in Medical Oncology in Sydney, Australia. He also completed a PhD in cancer drug discovery at The University of Sydney. His current research focus is in early phase clinical trials and lung cancer translational research. He also has a keen interest in the design and conduct of early and late phase clinical trials. As an early career researcher, he has received numerous awards and achievements including an International Association for the Study of Lung Cancer (IASLC) Fellowship 2018-2020, ASCO 2018, ESMO Asia 2019, WCLC 2020, and ASCO Breakthrough 2023 Merit Awards.
Education
Fellow, Royal Aust Coll of Physicians
Royal Australasian College of Physicians, Australia
Bachelor of Medicine, Bachelor of Surgery
University of New South Wales, Australia
Doctor of Philosophy
University of Sydney, Australia
Bachelor of Science in Medicine
University of New South Wales, Australia